![Johan Kördel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Johan Kördel
Directeur/Membre du Conseil chez
Breye Therapeutics ApS
Profil
Johan Kördel is currently a Board Director at Acacia Pharma, Inc. and a Director at Breye Therapeutics ApS.
He is also a Senior Advisor at Lundbeckfonden Ventures since 2010.
Previously, he served as a Board Director at DYSIS Medical Ltd. from 2013 to 2021, a Board Director at Atox Bio Ltd. from 2014 to 2021, a Board Director at Spero Therapeutics, Inc. from 2015 to 2018, a Board Director at VarmX BV from 2020 to 2021, and a Board Member at Aura Biosciences, Inc. from 2017 to 2021.
Postes actifs de Johan Kördel
| Sociétés | Poste | Début |
|---|---|---|
Breye Therapeutics ApS
 Breye Therapeutics ApS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel oral therapies for retinal vascular diseases | Directeur/Membre du Conseil | - |
Lundbeckfonden Ventures
 Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures is an active manager which provides equity funding for early and later-stage capital requirements, and provides management support. The firm targets companies operating in health technology sector, industries such as pharmaceuticals. Lundbeckfonden Ventures invests in companies located in Europe and North America, and looks to take minority stake positions in its investments, as well as a seat on the board. | Private Equity Investor | 01/01/2010 |
Acacia Pharma, Inc.
 Acacia Pharma, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Directeur/Membre du Conseil | 01/05/2022 |
Anciens postes connus de Johan Kördel
| Sociétés | Poste | Fin |
|---|---|---|
Varmx BV
 Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Directeur/Membre du Conseil | 31/10/2021 |
| AURA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 31/10/2021 |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Directeur/Membre du Conseil | 31/10/2021 |
DYSIS Medical Ltd.
 DYSIS Medical Ltd. Medical SpecialtiesHealth Technology Manufactures and distributes technological medical equipment for cervical cancer diagnostics | Directeur/Membre du Conseil | 31/10/2021 |
| SPERO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 31/08/2018 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
DYSIS Medical Ltd.
DYSIS Medical Ltd. Medical SpecialtiesHealth Technology Manufactures and distributes technological medical equipment for cervical cancer diagnostics | Health Technology |
Lundbeckfonden Ventures
Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures is an active manager which provides equity funding for early and later-stage capital requirements, and provides management support. The firm targets companies operating in health technology sector, industries such as pharmaceuticals. Lundbeckfonden Ventures invests in companies located in Europe and North America, and looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Health Technology |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Acacia Pharma, Inc.
Acacia Pharma, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
Varmx BV
Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Health Technology |
Breye Therapeutics ApS
Breye Therapeutics ApS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel oral therapies for retinal vascular diseases | Health Technology |
